We are pleased to announce that our consultant, Dr. Rebecca Arend of the University of Alabama at Birmingham (UAB), currently has two clinical trials that are dedicated to the treatment of carcinosarcoma patients!

1. Trial using Cabo, Opdivo and Keytruda for GYN Carcinosarcoma
   (ClinicalTrials.gov Identifier: NCT 04149275)

   This trial is tailored specifically for recurrent carcinosarcoma patients.

   This clinical trial is being conducted at the University of Alabama at Birmingham.
   

2. Trial using a Wnt modulator and Taxol for GYN Carcinosarcoma:
   Two additional arms of this study have been opened specific for patients with carcinosarcoma (uterine or ovarian).
   (ClinicalTrials.gov Identifier: NCT03395080)

   This clinical trial is being conducted at 17 locations in the US, including the University of Alabama, Birmingham, AL.

   Dr. Rebecca Arend, MD is the Principal Investigator for this multi-site study.

For more information on clinical trials, please click here.